Primary Site >> Stomach Cancer
Gene >> TOP2A
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Immunohistochemical staining for DNA topoisomerase I, DNA topoisomerase II-alpha and p53 in gastric carcinomas. PMID: 11396158 |
Ref: Targets of gene amplification and overexpression at 17q in gastric cancer. PMID: 11980659 |
Ref: Coamplified and overexpressed genes at ERBB2 locus in gastric cancer. PMID: 14991576 |
Ref: Topoisomerase IIalpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study. PMID: 16949920 |
Ref: Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients. PMID: 19061514 |
Ref: Evidence for predictive role of BRCA1 and bTUBIII in gastric cancer. PMID: 23532817 |
Ref: Association analysis of ERBB2 amplicon genetic polymorphisms and STARD3 expression with risk of gastric cancer in the Chinese population. PMID: 24291029 Ref: Molecular profiling in gastric cancer: examining potential targets for chemotherapy. PMID: 24844210 Ref: Detection of kinase amplifications in gastric adenocarcinomas. PMID: 25558650 |
Ref: Semi-comprehensive analysis of gene amplification in gastric cancers using multiplex ligation-dependent probe amplification and fluorescence in situ hybridization. PMID: 25743022 Ref: Tumor profiling of gastric and esophageal carcinoma reveal different treatment options. PMID: 25778705 Ref: ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression. PMID: 25980581 Ref: BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy. PMID: 26050197 Ref: Delineation of gastric cancer subtypes by co-regulated expression of receptor tyrosine kinases and chemosensitivity genes. PMID: 26396673 Ref: Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis. PMID: 26608463 Ref: Effects of siRNA-mediated silencing of myeloid cell leukelia-1 on the biological behaviors and drug resistance of gastric cancer cells. PMID: 26807186 |
Ref: Tumor profiling of co-regulated receptor tyrosine kinase and chemoresistant genes reveal different targeting options for lung and gastroesophageal cancers. PMID: 28078044 |
Ref: Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer. PMID: 28056823 Ref: Transcriptional Regulatory Network Analysis for Gastric Cancer Based on mRNA Microarray. PMID: 28078605 Ref: Molecular dysexpression in gastric cancer revealed by integrated analysis of transcriptome data. PMID: 28521423 Ref: TOP2A, GGH, and PECAM1 are associated with hematogenous, lymph node, and peritoneal recurrence in stage II/III gastric cancer patients enrolled in the ACTS-GC study. PMID: 28915696 Ref: Relationship between Topoisomerase II Alpha Overexpression and Prognosis in Chinese Gastric Cancer Patients. PMID: 29283334 |
Ref: Identification of Potential Key Genes Associated With the Pathogenesis and Prognosis of Gastric Cancer Based on Integrated Bioinformatics Analysis. PMID: 30065754 Ref: Cross-Database Analysis Reveals Sensitive Biomarkers for Combined Therapy for ERBB2+ Gastric Cancer. PMID: 30123134 Ref: Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network. PMID: 30336538 |